EUVIMEDEUVIMED entdecken
Beobachtungsstudie

An investigation into the contributing factors to survival of ARDS patients supported by veno-venous ECMO

Gavin Majithia-Beet iD, Roozbeh Naemi iD, Richard Issitt iD

Perfusion · 2025

DOI: 10.1177/02676591241297048 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Perfusion, 2025. Verfasst von Gavin Majithia-Beet und 2 weiteren Autor:innen. Beteiligte Einrichtung: Perfusion Department, Glenfield Hospital, Leicester, UK. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Respiratory Distress Syndrome, COVID-19, SARS-CoV-2. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to identify characteristics associated with survival during and post Extra Corporeal Membrane Oxygenation (ECMO) therapy, in patients with acute respiratory distress syndrome (ARDS) during the COVID-19 pandemic.

Methods

A retrospective observational study on 94 consecutive patients with confirmed COVID-19 induced ARDS supported by ECMO was carried out 49/94 (52.7%) patients survived to hospital discharge.

Results

Non-survivors were found to have significantly ( p < .05) higher: Pre-ECMO International normalized ratios (INR), carbon dioxide partial pressure ( p CO 2 ), Acute Kidney Injury (AKI) scores and blood urea levels. Also, lower pre-ECMO peak inspiratory pressures (PIP), mean arterial pressure, saturation of arterial oxygen (SaO 2 ), blood bicarbonate levels (HCO3), blood Ph and fewer trials off ECMO with shorter combined trial off times. Patients that did not survive were more likely to have renal impairment and have received peri-ECMO haemofiltration. Poor prognosis was significantly associated with: receiving pre-ECMO nitric oxide (HR = 3.047, CI = 1.247-7.447, p = .015), renal impairment (HR = 3.023, CI = 1.586-5.763, p < .001), AKI of 2 (HR = 3.611, CI = 1.382-9.441, p = .009) or 3 (HR = 3.275, CI = 1.235-8.685, p = .017), peri-ECMO haemofiltration (HR = 2.412, CI = 1.310-4.442, p = .005) and the ABO blood group B (HR = 3.103, CI = 1.335-7.212, p = .008). pre-ECMO high CO 2 (HR = 1.134, CI = 1.031-1.248, p = .010), blood lactate (HR = 1.350, CI = 1.156-1.576, p < .001), INR (HR = 2.571, CI = 1.438-4.598, p =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationRespiratory Distress SyndromeCOVID-19SARS-CoV-2HumansMaleFemaleRetrospective StudiesMiddle AgedAdultAgedAcute Kidney Injury

Stichwörter der Autor:innen

ARDSECMOacute respiratory distress syndromeextracorporeal membrane oxygenationsurvival

Autor:innen und Institutionen

  • Perfusion Department, Glenfield Hospital, Leicester, UK.
  • School of Health, Education, Policing and Sciences, Staffordshire University, Stoke-on-Trent, UK.
  • Centre for Human Movement and Rehabilitation, School of Health and Society, University of Salford, Manchester, UK.
  • Perfusion Department, Great Ormond Street Hospital, London, UK.
  • Institute of Cardiovascular Science, University College London, London, UK.

ORCID-Profile: Gavin Majithia-Beet, Roozbeh Naemi, Richard Issitt

Zitieren

APA

Majithia-Beet, G., Naemi, R., & Issitt, R. (2025). An investigation into the contributing factors to survival of ARDS patients supported by veno-venous ECMO. Perfusion. https://doi.org/10.1177/02676591241297048

Vancouver

Majithia-Beet G, Naemi R, Issitt R. An investigation into the contributing factors to survival of ARDS patients supported by veno-venous ECMO. Perfusion. 2025. doi:10.1177/02676591241297048

BibTeX
@article{MajithiaBeet2025,
  author = {Majithia-Beet, Gavin and Naemi, Roozbeh and Issitt, Richard},
  title = {An investigation into the contributing factors to survival of ARDS patients supported by veno-venous ECMO},
  journal = {Perfusion},
  year = {2025},
  doi = {10.1177/02676591241297048}
}
Kostenlos starten →